Skip to main content
. 2021 Oct 13;10(2):1691–1708. doi: 10.1007/s40122-021-00331-3

Table 2.

Summary of the total PRO scores and number of patients by domain for the part 2 population (N = 2419)

Assessment tool n or n (%) Mean (95% CI) score
EQ-5D-5L utility index score 2415 0.76 (0.75 to 0.77)
EQ-5D-5L VAS score 2419 67.3 (66.5 to 68.1)
EQ-5D-5L mobility*
 I have no problems in walking about 1928 (79.7) (78.10 to 81.31)
 I have slight problems in walking about 311 (12.9) (11.52 to 14.19)
 I have moderate problems in walking about 132 (5.5) (4.55 to 6.36)
 I have severe problems in walking about 40 (1.7) (1.15 to 2.16)
 I am unable to walk about 6 (0.2) (0.05 to 0.45)
 Missing 2 (0.1) (0.00 to 0.20)
EQ-5D-5L self-care*
 I have no problems washing or dressing myself 2206 (91.2) (90.07 to 92.32)
 I have slight problems washing or dressing myself 143 (5.9) (4.97 to 6.85)
 I have moderate problems washing or dressing myself 51 (2.1) (1.54 to 2.68)
 I have severe problems washing or dressing myself 14 (0.6) (0.28 to 0.88)
 I am unable to wash or dress myself 3 (0.1) (0.00 to 0.26)
 Missing 2 (0.1) (0.00 to 0.20)
EQ-5D-5L usual activities*
 I have no problems doing my usual activities 1229 (50.8) (48.81 to 52.80)
 I have slight problems doing my usual activities 546 (22.6) (20.91 to 24.24)
 I have moderate problems doing my usual activities 428 (17.7) (16.17 to 19.21)
 I have severe problems doing my usual activities 175 (7.2) (6.20 to 8.27)
 I am unable to do my usual activities 39 (1.6) (1.11 to 2.11)
 Missing 2 (0.1) (0.00 to 0.20)
EQ-5D-5L pain/discomfort*
 I have no pain or discomfort 541 (22.4) (20.70 to 24.03)
 I have slight pain or discomfort 635 (26.3) (24.50 to 28.00)
 I have moderate pain or discomfort 670 (27.7) (25.91 to 29.48)
 I have severe pain or discomfort 470 (19.4) (17.85 to 21.01)
 I have extreme pain or discomfort 99 (4.1) (3.30 to 4.88)
 Missing 4 (0.2) (0.00 to 0.33)
EQ-5D-5L anxiety/depression*
 I am not anxious or depressed 1063 (43.9) (41.97 to 45.92)
 I am slightly anxious or depressed 722 (29.8) (28.02 to 31.67)
 I am moderately anxious or depressed 437 (18.1) (16.53 to 19.60)
 I am severely anxious or depressed 150 (6.2) (5.24 to 7.16)
 I am extremely anxious or depressed 44 (1.8) (1.29 to 2.35)
 Missing 3 (0.1) (0.00 to 0.26)
HIT-6 total score 2415 65.2 (65.0 to 65.5)
HIT-6 total score grade*
 Little or no impact 29 (1.2) (0.77 to 1.63)
 Some impact 100 (4.1) (3.34 to 4.93)
 Substantial impact 157 (6.5) (5.51 to 7.47)
 Severe impact 2129 (88.0) (86.72 to 89.31)
 Missing 4 (0.2) (0.00 to 0.33)
mMIDAS total score 2380 25.1 (24.4 to 25.9)
Modified MIDAS disability grade*
 I 160 (6.6) (5.62 to 7.60)
 II 76 (3.1) (2.45 to 3.84)
 III 162 (6.7) (5.70 to 7.69)
 IV 1982 (81.9) (80.40 to 83.47)
 Missing 39 (1.6) (1.11 to 2.11)
MSQ-RFR score 2417 43.8 (43.0 to 44.6)
MSQ-RFP score 2415 59.2 (58.2 to 60.1)
MSQ-EF score 2416 50.5 (49.4 to 51.6)
WPAI percentage work time missed 1587 15.6 (14.3 to 16.9)
WPAI percentage impairment while working 1512 48.6 (47.2 to 49.9)
WPAI percentage overall work impairment 1496 52.6 (51.2 to 54.0)
WPAI percentage activity impairment 2410 56.4 (55.3 to 57.4)
HADS overall score 2395 14.6 (14.3 to 15.0)
HADS anxiety 2401 8.0 (7.8 to 8.2)
HADS depression 2401 6.7 (6.5 to 6.8)
HADS anxiety subscale—categorical*
 Below 11 1700 (70.3) (68.46 to 72.10)
 11 or above 701 (29.0) (27.17 to 30.79)
 Missing 18 (0.7) (0.40 to 1.09)
HADS depression subscale—categorical*
 Below 11 1923 (79.5) (77.89 to 81.10)
 11 or above 478 (19.8) (18.17 to 21.35)
 Missing 18 (0.7) (0.40 to 1.09)

*Only 95% CI is reported. CIs were calculated using Wald formula/method

CI confidence interval, EF emotional function, EQ-5D-5L EuroQoL 5 dimensions, 5 levels, HADS Hospital Anxiety and Depression, HIT-6 headache impact test, mMIDAS modified Migraine Disability Assessment, MSQ migraine-specific quality of life, N number of patients included to analyze the respective questionnaire, PRO patient-reported outcome, RFP role function-preventive, RFR role function-restrictive, VAS visual analog scale, WPAI work productivity and activity impairment